Purpose This review offers an informed insight on the pathophysiology of ocular graft-versus-
host disease in addition to up-to-date recommendations for monitoring and management …

Chronic graft-versus-host disease (cGvHD) is a major concomitant phenomenon in
recipients of allogeneic hematopoietic stem cell transplantations, affecting multiple organ …

Background. The administration of systemic immunosuppressive agents to recipients of solid
organ or bone marrow transplants results in an immunocompromised status. As the number …

Ocular graft-versus-host disease (GVHD) occurs in more than half of patients who develop
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …

Graft versus host disease (GVHD) is a common complication of allogeneic stem cell
transplantation (allo-SCT). Ocular GVHD develops in approximately 40-60% of patients …

Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of
disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a …

Graft-versus-host disease (GVHD) is a common cause of morbidity and mortality after
allogeneic hematopoietic stem cell transplantation. Systemic findings involving the skin …

Ocular graft-versus-host disease (oGVHD) occurs as a complication following hematopoietic
stem cell transplantation and is associated with significant ocular morbidity resulting in a …

Graft-versus-host disease (GVHD) is a major complication that occurs following allogeneic
hematopoietic stem cell transplantation, which is a potential curative therapy used in a …

Hematopoietic stem cell transplantation is important in the management of several
lymphoproliferative and bone marrow disorders. Graft-versus-host disease (GVHD) involves …